Can eculizumab be discontinued in aHUS?: Case report and review of the literature

Por Sahutoglu, Tuncay, Basturk, Taner, Sakaci, Tamer, Koc, Yener, Ahbap, Elbis, Sevinc, Mustafa, Kara, Ekrem, Akgol, Cuneyt, Caglayan, Feyza Bayraktar, Unsal, Abdulkadir, Daha, Mohamed R.
Publicado no Medicine (Baltimore) (2016)

Serum VEGF-C levels as a candidate biomarker of hypervolemia in chronic kidney disease

Por Sahutoglu, Tuncay, Sakaci, Tamer, Hasbal, Nuri B., Ahbap, Elbis, Kara, Ekrem, Sumerkan, Mutlu C., Sevinc, Mustafa, Akgol, Cuneyt, Koc, Yener, Basturk, Taner, Unsal, Abdulkadir
Publicado no Medicine (Baltimore) (2017)

Plasma resistant atypical hemolytic uremic syndrome associated with a CFH mutation treated with eculizumab: a case report

Por Sevinc, Mustafa, Basturk, Taner, Sahutoglu, Tuncay, Sakaci, Tamer, Koc, Yener, Ahbap, Elbis, Akgol, Cuneyt, Kara, Ekrem, Brocklebank, Vicky, Goodship, Tim HJ, Kavanagh, David, Unsal, Abdulkadir
Publicado no J Med Case Rep (2015)

The relationship between serum albumin levels and 24-h ambulatory blood pressure monitoring recordings in non-diabetic essential hypertensive patients

Por Ahbap, Elbis, Sakaci, Tamer, Kara, Ekrem, Sahutoglu, Tuncay, Koc, Yener, Basturk, Taner, Sevinc, Mustafa, Akgol, Cuneyt, Kayalar, Arzu O., Ucar, Zuhal A., Bayraktar, Feyza, Unsal, Abdulkadir
Publicado no Clinics (Sao Paulo) (2016)

Outcome of 121 patients with renal amyloid a amyloidosis

Por Ahbap, Elbis, Kara, Ekrem, Sahutoglu, Tuncay, Basturk, Taner, Koc, Yener, Sakaci, Tamer, Sevinc, Mustafa, Akgol, Cuneyt, Ucar, Zuhal Atan, Kayalar, Arzu Ozdemir, Bayraktar, Feyza, Ozagari, Ayse Aysim, Unsal, Abdulkadir
Publicado em 2014

Clinical outcomes and mortality in elderly peritoneal dialysis patients

Por Sakacı, Tamer, Ahbap, Elbis, Koc, Yener, Basturk, Taner, Ucar, Zuhal Atan, Sınangıl, Ayse, Sevınc, Mustafa, Kara, Ekrem, Akgol, Cuneyt, Kayalar, Arzu Ozdemır, Caglayan, Feyza Bayraktar, Sahutoglu, Tuncay, Ünsal, Abdulkadir
Publicado no Clinics (Sao Paulo) (2015)